Big Data in Healthcare by Product & Service (Hardware/Software and Services), Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, and Diagnostic Analytics), Deployment (On-premise, Cloud, and Hybrid), Application (Clinical Data Management, Patient Management, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a robust CAGR forecast till 2032 owing to the rising prevalence of chronic disease and increasing technological innovations and product launches.
The big data in healthcare market is estimated to grow at a CAGR of 20.11% during the forecast period from 2025 to 2032, reaching USD 338.96 billion by 2032. Key factors such as growing adoption of electronic health records (EHRs), the rise of digital health solutions, and continuous advancements in data analytics and technological innovation are creating a favorable environment for sustained market growth. As a result, the market is poised for robust and steady expansion from 2025 to 2032.
Discover how Big Data in Healthcare Market innovations are transforming patient outcomes by 2032
Big Data in Healthcare Market Dynamics
According to GLOBOCAN (2024), approximately 20 million new cancer cases were reported globally in 2022, with this number projected to rise to 32.6 million by 2045. In the Eastern Mediterranean Region alone, over 788,000 cancer diagnoses were recorded in 2022, expected to nearly double to around 1.57 million by 2045. Big Data in Healthcare Mechanism plays a crucial role in identifying cancer risk factors by analyzing genetic profiles, lifestyle data, and environmental exposures, supporting early diagnosis through advanced image analysis and pattern recognition.
Similarly, cardiovascular diseases are increasing worldwide. Data from the British Heart Foundation (2024) revealed approximately 640 million people affected by heart and circulatory diseases globally, with around 67 million new diagnoses each year. Patients benefit from real-time data collection via wearable devices and IoT-enabled monitors. Therefore, the rising prevalence of chronic diseases such as cancer and cardiovascular disorders are key market drivers.
The growing adoption of EHRs and digital health tools is also fueling growth. According to the European Commission (2024), 79% of healthcare providers had adopted EHRs in 2023, up from 72% the previous year. Big data aggregates patient information across systems to enhance care coordination and analytics.
Key market players continue to introduce innovative tools. In October 2023, Microsoft launched big data and AI solutions designed to help healthcare organizations unlock insights and improve experiences for both patients and clinicians. However, data privacy and security concerns, along with high development and implementation costs, remain key constraints that may limit market growth.
Key Players in the Big Data in Healthcare Market
Some of the key Big Data in Healthcare Companies operating in the market include IBM, Google LLC, Koninklijke Philips N.V., TEMPUS, Epic Systems Corporation, The Apache Software Foundation, Cloudian Object Storage, Microsoft, Yalantis, Altair Engineering Inc., Oracle, Flatiron Health, Kaiser Permanente, Palantir Technologies Inc., GE HealthCare, UnitedHealth Group, Innovaccer, Health Catalyst, Apixio, and others.
Big Data in Healthcare Market Segment Analysis
The big data in healthcare market is segmented by Product & Service (Hardware/Software and Services), Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, and Diagnostic Analytics), Deployment (On-premise, Cloud, and Hybrid), Application (Clinical Data Management, Patient Management, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the type segment, the predictive analytics category is estimated to account for the largest market share in 2024. This growth is primarily driven by the increasing global prevalence of chronic diseases and the wide-ranging benefits predictive analytics offers. Predictive analytics enables early detection and prevention by identifying at-risk individuals before symptoms appear, using historical health data, genetic profiles, and lifestyle patterns.
Predictive models also identify patients at high risk of hospital readmission within 30 days after discharge, supporting targeted follow-up care and reducing readmission rates and associated costs. Additionally, predictive analytics supports personalized treatment planning by analyzing genomic, demographic, and clinical data.
Ongoing industry innovation is further accelerating this category’s growth. In April 2024, Verana Health launched its Qdata® Thyroid Eye Disease (TED) module – a curated dataset containing real-world data from over 250,000 de-identified patients – enhancing the precision and utility of predictive models in clinical settings. The combination of clinical advantages, growing disease burden, and product launches by key industry players is expected to drive substantial growth in predictive analytics from 2025 to 2032.
North America Dominates the Big Data in Healthcare Market
North America is projected to hold the largest share of the big data in healthcare market in 2024, driven by rising chronic disease prevalence, supportive regulatory policies, and increased partnerships between healthcare and technology companies.
According to GLOBOCAN (2024), cancer cases in the U.S. reached 2.38 million in 2022 and are projected to rise to 2.79 million by 2030. The American Cancer Society (2025) estimated 2.04 million new cancer cases in 2025, boosting demand for Big Data in Healthcare Medical devices and platforms offering personalized treatment planning, early detection, and therapy simulation.
Cardiovascular disease is another major driver. The CDC (2024) reported that in 2022, around 6.2 million adults in the U.S. had heart failure and 20.5 million were living with coronary heart disease. Big data helps in early diagnosis, risk prediction, and tailored treatment simulations. Furthermore, according to the CDC (September 2023), approximately 6.7 million individuals aged 65 and older were living with Alzheimer’s disease in the U.S., projected to reach 13.9 million by 2060 – with big data tools emerging as a promising asset in disease progression modeling, outcome prediction, and drug discovery.
The growing adoption of EHR solutions is also significantly driving market growth in the region. According to the American Hospital Association (2022), over 96% of hospitals and 78% of office-based physicians in the U.S. had adopted EHR systems. In August 2023, HCA Healthcare announced a collaboration with Google Cloud to harness generative AI technologies, focusing on automating clinical documentation to allow physicians and nurses to spend more time on direct patient care. These factors collectively solidify North America’s position as the dominant region in the global market.
Recent Developmental Activities in the Big Data in Healthcare Market
- In June 2025, Databricks and Synapxe announced a strategic partnership to accelerate data and AI-enabled innovation in Singapore’s public healthcare system, with Synapxe adopting the Databricks Data Intelligence Platform to power HEALIX – a next-generation national health data platform focused on real-time insights, data security, and democratization.
- In July 2024, Verana Health and HealthVerity announced a partnership to advance real-world evidence (RWE) in healthcare research, combining curated real-world data with a privacy-preserving data ecosystem to foster innovation in patient care and decision-making.
- In October 2023, Fujitsu and TOPPAN Holdings announced a collaboration to expand their medical big data business, utilizing anonymized electronic medical record (EMR) data to support drug development and enhance medical support services through advanced data analytics.
Explore leading Big Data in Healthcare Companies shaping the future of global healthcare analytics
Conclusion
The big data in healthcare market is on a transformative growth trajectory, underpinned by the surging burden of chronic diseases, rapid adoption of digital health technologies, and a robust wave of product launches and strategic collaborations. The integration of Big Data in Healthcare analytics into clinical workflows is enabling more precise diagnostics, personalized care pathways, and operational efficiencies across health systems globally. With predictive analytics leading segment growth and North America anchoring regional dominance, the market is well-positioned to achieve USD 338.96 billion by 2032. As innovation continues to reshape healthcare delivery, big data stands as a foundational pillar of the industry’s digital transformation.
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharmaceutical companies by providing comprehensive end-to-end solutions to improve their performance. It also offers healthcare consulting services that leverage market analysis to accelerate business growth and overcome challenges with practical approaches.
Media contact
Name: Abhishek kumar
E-mail:abhishek@delveinsight.com
